We revolutionize drug delivery and diagnostics for women
We develop intelligent vaginal rings featuring personalized, remotely programmable drug delivery and diagnostics with smart data transmission. The vaginal wall has the ideal anatomical profile for uptake of medication and diagnostic monitoring.
Applicable for treatment of a wide variety of chronic diseases.
February 25th 2020: The MedRing functional model, based on the final dimensions, is ready. Watch the video on the page “Our Science”
December 5th 2019: LiGalli got awarded the MIT subsidy from the Dutch government. We look forward to working with our new partner Gimix.
October 10th 2019: LiGalli raises EUR 7 million financing to finalize their novel vaginal ring. Press release can be found here.